Home
>
National Drug Code (NDC)
>
sildenafil
sildenafil - 55111-372-05 - (sildenafil)
Drug Information of sildenafil
| Product NDC: | 55111-372 |
| Proprietary Name: | sildenafil |
| Non Proprietary Name: | sildenafil |
| Active Ingredient(s): | 20 mg/1 & nbsp; sildenafil |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of sildenafil
| Product NDC: | 55111-372 |
| Labeler Name: | Dr. Reddy's Laboratories Limited |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA202598 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20121107 |
Package Information of sildenafil
| Package NDC: | 55111-372-05 |
| Package Description: | 500 TABLET, FILM COATED in 1 BOTTLE (55111-372-05) |
NDC Information of sildenafil
| NDC Code | 55111-372-05 |
| Proprietary Name | sildenafil |
| Package Description | 500 TABLET, FILM COATED in 1 BOTTLE (55111-372-05) |
| Product NDC | 55111-372 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | sildenafil |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20121107 |
| Marketing Category Name | ANDA |
| Labeler Name | Dr. Reddy's Laboratories Limited |
| Substance Name | SILDENAFIL CITRATE |
| Strength Number | 20 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Phosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA] |
